ACLX · As filed with the SEC

Arcellx balance sheet, by quarter

The statement as Arcellx presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.

CONSOLIDATED BALANCE SHEETS · USD

USDQ4 2025
Dec 31, 2025
Q3 2025
Sep 30, 2025
Q2 2025
Jun 30, 2025
Q1 2025
Mar 31, 2025
Cash and cash equivalents80,262,00079,005,00062,336,00080,861,000
Marketable securities370,072,000382,378,000390,767,000462,404,000
Restricted cash, current000208,000
Prepaid expenses and other current assets11,849,00010,698,00010,792,00010,681,000
Total current assets462,183,000472,081,000463,895,000554,154,000
Restricted cash, non-current2,616,0002,616,0002,418,0002,418,000
Marketable securities, non-current69,716,000114,591,00084,502,00021,942,000
Property and equipment, net42,639,00043,076,00044,472,00045,568,000
Operating lease right-of-use assets23,828,00023,225,00023,416,00023,603,000
Prepaid research and development expenses and other long-term assets3,008,000329,000383,000397,000
Total assets603,990,000655,918,000619,086,000648,082,000
Liabilities, redeemable convertible preferred stock, and stockholders' equity (deficit)
Current liabilities:
Accounts payable5,576,0004,204,0002,079,0004,369,000
Accrued liabilities35,079,00046,967,00053,034,00043,359,000
Operating lease liabilities, current portion7,580,0007,471,0007,416,0007,361,000
Finance lease liabilities, current portion0000
Contract liability to related party55,967,00059,750,00059,321,00057,372,000
Total current liabilities104,202,000118,392,000121,850,000112,461,000
Operating lease liabilities, net of current portion44,339,00044,323,00045,097,00045,831,000
Contract liabilities, net of current portion to related party53,098,00052,426,00059,916,00069,447,000
Other non-current liabilities0003,437,000
Total liabilities201,639,000215,141,000226,863,000231,176,000
Stockholders' equity
Common stock, par value of $0.001 per share; 1,000,000,000 shares authorized and 57,929,325 shares issued and outstanding as of December 31, 2025; 1,000,000,000 shares authorized and 54,293,597 shares issued and outstanding as of December 31, 202456,00056,00054,00054,000
Additional paid-in capital1,127,214,0001,107,665,0001,003,635,000975,301,000
Accumulated other comprehensive income843,000706,000403,000649,000
Accumulated Deficit(725,762,000)(667,650,000)(611,869,000)(559,098,000)
Total stockholders' equity402,351,000440,777,000392,223,000416,906,000
Total liabilities and stockholders' equity603,990,000655,918,000619,086,000648,082,000

As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.